Beta Blockers and Lactation: An Update

Beta-adrenergic antagonists are one of the most commonly used class of agents in the treatment of hypertension. They have also demonstrated utility in the treatment of angina pectoris and certain arrhythmias and for the reduction in mortality following a myocardial infarction. The use of this class...

Full description

Saved in:
Bibliographic Details
Published in:Journal of human lactation 2000-08, Vol.16 (3), p.240-245
Main Authors: Shannon, Meghan E., Malecha, Susan E., Cha, Amy J.
Format: Article
Language:English
Subjects:
Adrenergic beta-Antagonists - adverse effects
Adrenergic beta-Antagonists - pharmacokinetics
Adult
Female
Humans
Hypertension - drug therapy
Infant
Milk, Human - chemistry
Nursing
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Beta-adrenergic antagonists are one of the most commonly used class of agents in the treatment of hypertension. They have also demonstrated utility in the treatment of angina pectoris and certain arrhythmias and for the reduction in mortality following a myocardial infarction. The use of this class of agents creates the potential for beta-blocker exposure among lactating women. This review focuses on the most up-to-date data regarding the more common agents—metoprolol, atenolol, propranolol, carvedilol, nadolol, sotalol, and betaxolol—and their safety in lactating women.
ISSN:0890-3344
1552-5732
DOI:10.1177/089033440001600313